You are currently viewing our desktop site, do you want to download our app instead?
Moneyweb Android App Moneyweb iOS App Moneyweb Mobile Web App

NEW SENS search and JSE share prices

More about the app

LATEST NEWS FOR Ascendis Health Ltd.  

Ascendis Health is a South African-based international health and wellness company marketing leading brands and products.... [more info]

Ascendis falls 4.5% as recapitalisation gets shareholder approval

5 Oct 2021 /  Suren Naidoo  
With 98.5% voting in favour.

Ascendis will spend R290m – more than its market cap – on recapitalisation

6 Sep 2021 /  Moneyweb   3
Legal fees on three transactions total R195m.

SA minority investors to form activist group to take on Tongaat

31 Aug 2021 /  Promit Mukherjee, Reuters  
To press for change at debt-laden sugar producer.

Simon’s weekly wrap: A stronger rand and the rise of contactless payments

14 May 2021 /  Simon Brown  
This week MoneywebNOW looked at a possible commodities supercycle, Raubex, simplicity versus complexity when valuing a company and more.

Tobacco companies looking for a new future

13 May 2021 /  Simon Brown   
Kruger International's Mia Kruger unpacks the latest Naspers/Prosus share shuffle and the Lewis update. Rishaad Hajee from Philip Morris on the end of cigarette sales. Small caps analyst, Anthony Clark takes a look at the Ascendis debt deal.

[TOP STORY] Will debt-laden Ascendis have to sell its crown jewel?

26 Jan 2021 /  Simon Brown  
‘Blantyre and L1 Health have just added to the cocktail of what Ascendis could potentially become in the next 12 to 18 months’ – Small-cap analyst Anthony Clarke.

Is Redefine’s Reit status under threat?

26 Jan 2021 /  Simon Brown  
Garreth Elston of Reitway Global talks Redefine not paying a dividend. Small-caps analyst Anthony Clark on Blantyre's stake in Ascendis's debt and Anchor's Deryck Janse van Rensburg on markets surging.

Upward trajectories and lines in the sand

19 Oct 2020 /  Ann Crotty   2
M&R's well-timed share awards, PPC's timing tightrope walk, some relief during a torrid time for Ascendis, and time to face the music for more than 5 400 Eskom employees.

Luxury markets, Alviva interims and exploring the myths around wills

30 Sep 2020 /  Simon Brown   
Mia Kruger of Kruger International on luxury markets, the Palantir listing and Ascendis results. Alviva CEO, Pierre Spies talks the company's financials and the shift into services. Hilary Dudley of Citadel Fiduciary on the ins and outs of wills.

Advanced Level 3 lockdown, when to sell and Safair in the air once more

18 Jun 2020 /  Simon Brown  
FNB Wealth and Investment's Chantal Marx discusses the further opening of the economy and Aspen's share price reacting to hopes of a new Covid-19 wonder drug. Gary Booysen of Rand Swiss on trader vs investor. FlySafair's CEO Elmar Conradie gives an update following the resumption of flights.

Matjila, a ‘powerful’ man … or not

19 Jul 2019 /  Tebogo Tshwane   2
Did former PIC CEO Dan Matjila use his position to lean on PIC beneficiaries for favours?

‘Dr Dan didn’t lead, he ruled over the PIC’

27 May 2019 /  Tebogo Tshwane    4
Former PIC CEO's overarching influence, and the business people linked to him.

Netcare CEO forced to dump shares worth R200m

23 May 2019 /  Hilton Tarrant   10
Price slump wipes out his entire stake in the group …

Rand weaker after US Fed holds lending rates, stocks gain

2 May 2019 /  Reuters  
Sentiment focused on local elections next week.

Ascendis sells Bioscience business for R480m

2 May 2019 /  Nqobile Dludla, Reuters    1
The business will be sold to a consortium comprising RMB Ventures, Nedbank Private Equity and some members of the Biosciences division.

Enter company name or share code:

Enter company name or share code:


Follow us: